Phase 2 Open-label Study of Alum-adjuvanted Chikungunya Virus-like Particle Vaccine (PXVX0317)

NCT03992872 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Chikungunya

Interventions

BIOLOGICAL: Chikungunya

Sponsor

Bavarian Nordic

Collaborators

[object Object]
[object Object]